Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis

在接受血液透析的2型糖尿病患者中,通过瞬时连续血糖监测系统测定的糖化白蛋白和估算的糖化血红蛋白A1c水平评估的血糖控制水平存在显著差异。

阅读:1

Abstract

We aimed to investigate if estimated hemoglobin A1c (eHbA1c) levels determined using a flash continuous glucose monitoring system could be an indicator of glycemic control status in hemodialysis patients with diabetes. Hemodialysis patients with type 2 diabetes were recruited. eHbA1c levels were measured using the FreeStyle Libre Flash Glucose Monitoring System(®) . A total of 18 hemodialysis patients with diabetes were included in the study. The eHbA1c(GA) - calculated based on glycated albumin level, and body mass index and serum hemoglobin concentration were also included in the formula - was higher than the eHbA1c in most patients. Furthermore, the eHbA1c(GA)  - eHbA1c values were >2% in all patients with body mass index <18.5 kg/m(2) ; the maximal value was 4.1%. This study shows that eHbA1c can be used as a reliable indicator for evaluating glycemic control and avoiding hypoglycemia in hemodialysis patients with diabetes, particularly those with decreased body mass index.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。